About
Basic Data Updated:
1 month agoFounded in 1959, Overseas Pharma Private Limited is a renowned company that specializes in the development and manufacturing of generic pharmaceuticals. With a wide range of products such as Asmabron, Betacort, C.B.Calcium, Combisules Forte, and Creosil NF, the company has established itself as a leader in the industry. ISO 9001:2015 and GMP certified, OPPL is committed to providing high-quality and affordable medications to its customers. The company's registered office is situated in Bangalore, Karnataka, showcasing its strong presence in the region. With a dedicated team and state-of-the-art facilities, OPPL continues to make a significant impact in the pharmaceutical world.
Industry
Company Details
- Location
Bangalore, Karnataka, India
- Website12224421
- Telephone12224421
- Email Address12224421
- Social Media12224421
CIN/LLPIN/FCRN | U24119KA1959PTC001361 |
Company No. | 001361 |
Company Classification | Private Limited Indian Non-Government Company |
Incorporation Date | 18 Aug 1959 |
Date of AGM | 29 Sep 2023 |
Date of Balance Sheet | 31 Mar 2023 |
Listing Status | Unlisted |
ROC Code | Roc Bangalore |
Products or Services related to Overseas Pharma Private Limited
Financials of Overseas Pharma Private Limited
Overseas Pharma Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 53.62% increase. The company also saw a substantial improvement in profitability, with a 234.75% increase in profit. The company's net worth moved up by a moderate rise of 2.81%.
Corporate Structure
Unlock access to Overseas Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
People in Overseas Pharma Private Limited
Unlock and access historical data on people associated with Overseas Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Board Members(4)
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Canara Bank Creation Date: 15 Feb 2021 | ₹2.20 M | Open |
Deals i
Gain comprehensive insights into the Deals and Valuation data of Overseas Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Overseas Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alert
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Related Corporates (Common Directorship)
Dr. Ramesh Cardiac And Multispeciality Hospital Private Limited
Active 29 years 5 daysNerendranath Venkatachala is a mutual person
Medisync Health Management Services Private Limited
Active 5 years 10 monthsNerendranath Venkatachala is a mutual person
Vertexhealth Comprehensive Health Servic Es Llp
Active 5 years 11 monthsNerendranath Venkatachala is a mutual person
Hindustan Pharma Distributors Private Limited
Active 2 years 9 monthsNerendranath Venkatachala is a mutual person
Sri Naga Sai Healthcare Private Limited
Active 12 years 11 monthsNerendranath Venkatachala is a mutual person
Disease Management Association Of India
Active 2 years 3 monthsNerendranath Venkatachala is a mutual person
Recent activity within the organization
Annual General Meeting
Overseas Pharma Private Limited last Annual general meeting of members was held on 29 Sep 2023 as per latest MCA records.
29 Sep 2023Balance Sheet
Overseas Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Bangalore.
31 Mar 2023Charges
A charge with Canara Bank amounted to Rs. 22.00 Lakh with Charge ID 100426825 was registered on 15 Feb 2021.
15 Feb 2021Director Appointment
Nerendranath Venkatachala was appointed as a Director was appointed as a Director on 16 Jan 2017 & has been associated with this company since 7 years 4 months .
16 Jan 2017Director Appointment
Manjula Krishnappa was appointed as a Director was appointed as a Director on 16 Jan 2017 & has been associated with this company since 7 years 4 months .
16 Jan 2017
Frequently asked questions
What is the Incorporation or founding date of Overseas Pharma Private Limited?